期刊文献+

罗格列酮对胰岛素抵抗大鼠主动脉内皮功能的影响及其机制的研究 被引量:2

Effects and Mechanisms of Rosiglitazone on Aortic Endothelium-Dependent Vasodilation in Insulin-Resistance Rats
下载PDF
导出
摘要 目的:观察罗格列酮对胰岛素抵抗大鼠主动脉内皮依赖性血管舒张和一氧化氮(NO)含量、内皮型一氧化氮合酶(eNOS)、磷脂酰肌醇-3激酶及蛋白激酶B表达的影响。方法:4~6周龄雄性SD大鼠予高糖高脂喂养8周,建立胰岛素抵抗模型,分为对照组和治疗组,每组各15只,治疗组用罗格列酮[3mg/(kg·d)]干预8周,另取15只正常大鼠为正常组。实验终止时用葡萄糖输注率评价胰岛素抵抗,观察大鼠离体主动脉对乙酰胆碱依赖性血管舒张反应,Griess重氮化反应法检测主动脉NO含量,逆转录聚合酶链反应方法检测磷脂酰肌醇-3激酶、蛋白激酶B和eNOS mRNA表达,电镜观察主动脉超微结构。结果:对照组葡萄糖输注率、主动脉内皮依赖性舒张功能、NO浓度、磷脂酰肌醇-3激酶、蛋白激酶B、eNOS mRNA表达较正常组均显著降低(P〈0.01),治疗组上述指标均显著升高(P〈0.01)。透射电镜检查可见对照组主动脉内皮细胞和内皮下结构的病理改变,治疗组胸主动脉超微结构接近正常。结论:胰岛素抵抗大鼠存在内皮依赖性舒张功能紊乱和主动脉NO浓度、磷脂酰肌醇-3激酶、蛋白激酶B、eNOS mRNA表达下降,用罗格列酮治疗可改善其内皮功能,增强NO产生和磷脂酰肌醇-3激酶、蛋白激酶B、eNOS mRNA表达。 Objective:To study the effects of rosiglitazone on aortic endothelium-dependent vasodilation, nitric oxide(NO) production, expression of endothelial nitric oxide synthase( eNOS), phosphatidylinositol 3-kinase(PI3K) and protein kinase B (PKB) in rats with insulin-resistance(IR). Methods: Insulin resistance(IR) rat model was established in 4- 6 week-old male SD rats by high glucose and high fat feed for 6 weeks, IR rat were randomly divided into control group and rosiglitazone-treated group. Rosiglitazone-treated rats were given rosiglitazone 3 rag/( kg · d) for 8 weeks, other 15 normal rats were as normal control group. Insulin-resistance was evaluated by glucose infusion rate of euglycemic hyperinsulinemic clamp technique at the end of trial. Achtylcholine-induced vasodilation response in isolated aortic rings were observed and aortic NO concentration were measured using Griess Reaction. Expression of eNOS-, P13K-, and PKB mRNA of aorta were assayed by RT-PCR meatheds. Uhrastructure of aorta were measured by electron microscopy. Results: Glucose infusion rate, endothelium-dependent vasodilation, NO concentration and the expression of eNOS-,PI3K-, PKB mRNA in isolated aortic rings decreased significantly in IR control group compared with in normal control group( P 〈 0. 01 ). While those indexs in Rosiglitazone-treated group increased significantly ( P 〈 0. 01 ). Pathologic changes of aortic ultrastructure can be found in IR control group while the ultrastrueture of aorta in Rosiglitazone-treated group was nearly normal. Conclusion:There are endothelium-dependent vasodilation dysfunction in rats with IR. NO concentration, PI3K-, PKB-, and eNOS mRNA expression of aorta also decrease in those rats. Treatment with rosiglitazon can improve endothelial function, increase aortic NO production and PI3K-, PKB-,and eNOS mRNA expression in IR rats.
出处 《中国循环杂志》 CSCD 北大核心 2007年第5期385-389,共5页 Chinese Circulation Journal
基金 湖南省科技厅基金(06sk3023)
关键词 胰岛素抵抗 罗格列酮 内皮依赖性血管舒张 一氧化氮 内皮型一氧化氮合酶 Insulin resistance Rosiglitazone Endothelium-dependent vasodilation Nitric oxide Endothelial nitric oxide synthase
  • 相关文献

参考文献9

  • 1Kobayashi T,Taguchi K,Yasuhiro T,et al.Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model.Hypertension,2004,44(6):956-962.
  • 2丁世英,申竹芳,陈跃腾,谢明智.血糖钳技术评价两种胰岛素抵抗动物模型[J].中国糖尿病杂志,2001,9(5):286-289. 被引量:32
  • 3王珊,江俊麟,贾素洁,李年生,张晓红,杨栋梁,李元建.罗格列酮对糖尿病大鼠血管内皮损伤的保护作用与一氧化氮合酶抑制物的关系[J].中南药学,2005,3(3):131-135. 被引量:8
  • 4Jook JE,Hannemann MM.Adverse endothelial function and the insulin resistance syndrome.J Intern med,2000,247:425-431.
  • 5Cohen RA.Role of nitric oxide in diabetic complications.Am J Ther,2005,12(6):499-502.
  • 6Fulton D,Gratton JP,McCabe T,et al.Regulation of endothelium-derived nitric oide production by the protein kinase Akt.Nature,1999,399:597-601.
  • 7Inoue M,Itch H,Tanaka T,et al.Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator activated receptor.Arterioscler Thromb Vase Biol,2001,21:560-566.
  • 8Reusch JE,Regensteiner JG,Watson PA.Novel actions of thiazolidinediones on vascular function and exercise capacity.Am J Med,2003,8,115(Suppl8A):69S-74S.
  • 9Cho DH,Choi YJ,Jo SA,et al.Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone:evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways.J Biol Chem,2004,23,279(4):2499-2506.

二级参考文献17

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2[1]Xiong Y,Fu YF,Fu SH,et al. Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes [J].J Cardiovasc Pharmacol,2003,42(2):191
  • 3[2]Boger RH,Bode-Boger SM,Tsao PS,et al. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes [J].J Am Coll Cardiol,2000,36(7): 2287
  • 4[3]Pistrosch F,Passauer J,Fischer S,et al. In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control [J].Diabetes Care,2004,27(2):484
  • 5[4]Stuhlinger MC,Abbasi F,Chu JW,et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor[J].JAMA,2002,287(11):1420
  • 6[5]Pasceri V,Wu HD,Willerson JT,et al. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators[J].Circulation,2000,101(3):235
  • 7[6]Diep QN,El Mabrouk M,Cohn JS,et al. Structure,endothelial function,cell growth,and inflammation in blood vessels of angiotensin Ⅱ-infused rats: role of peroxisome proliferator-activated receptor-gamma[J].Circulation,2002,105(19): 2296
  • 8[7]Jiang JL,Li NS,Li YJ,et al. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthases inhibitor level [J].Br J Pharmacol,2002,135 (5): 1175
  • 9[8]Calver A,Collier J,Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes[J].J Clin Invest,1992,90(6): 2548
  • 10[9]Tilton RG,Chang K,Hasan KS,et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation [J].Diabetes,1993,42(2): 221

共引文献38

同被引文献44

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部